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Two new trinorcadalenes, parviflorals A and B (1 and 2), and four new bis-trinorcadalenes, 
parviflorals C−F (3−6), together with two known trinorcadalenes, syriacusins A (7) and C 
(8), and two known compounds scopoletin (9) and stigmasterol have been isolated from the 
roots of Decaschistia parviflora. Their structures were established by spectroscopic 
techniques.  The CD spectra of the bis-trinorcadalenes (3−6) identified their absolute 
configurations at the binaphthyl axis.  Further, the structure of 6 was confirmed by a single-
crystal X-ray crystallographic analysis.  Compounds 2 and 6 showed antimalarial activity 
against Plasmodium falciparum with IC50 values of 11.45 and 6.85 M, respectively.  
Compounds 1, 5, 7 and 8 exhibited weak antifungal activity against Candida albicans with 
IC50 values in the range of 37.03−197.68 M.  Compounds 1−3 and 5−8 showed weak 
antimycobacterial activity against Mycobacterium tuberculosis with MIC values in the range 
of 54.30−192.13 M.  In addition, several of these compounds possessed cytotoxicity 
towards the cancer cell lines, KB, MCF7 and NCI-H187 with IC50 values in the range of 













Decaschistia parviflora Kurz (Malvaceae) is a small shrub, up to 1 m in height, 
growing throughout Thailand.  It is known as “Thong Phun Dun” or “Chaba Nu” in Thai and 
the fresh root is used by local people as an embrocation in animals (Pharmaceutical Science, 
1996).  The genus Decaschistia comprises ca. 16 species distributed from India through 
Southeast Asia to Australia. Five species, Decaschistia crotonifolia, D. harmadii, D. 
intermedia, D. siamensis, and D. parviflora have been found in Thailand (Smitinand, 2001).  
Only D. crotonifolia has been investigated phytochemically, resulting in the isolation of three 
flavonols; gossypitrin, quercimeritrin, and gossypin (Radhakrishniah, 1981).  As part of our 
search for bioactive compounds from Thai plants we found that the crude EtOAc extract from 
the roots of D. parviflora had cytotoxicity against a KB cancer cell line with an IC50 value of 
6.25 µg/mL. We report herein the isolation, characterization, and bioactivities of the new 
trinorcadalenes, 1 and 2, the new binaphthyl derivatives, 3−6, and four known compounds 
from the root extracts of D. parviflora.   
 
2. Results and Discussion 
Air-dried roots of D. parviflora were extracted sequentially with hexane and EtOAc.  
The crude extracts were separated by column chromatography and crystallization to yield six 
new trinorcadalenes, parviflorals A-F (1−6) and four known compounds, syriacusins A (7) 
and C (8) (Yoo et al., 1998), scopoletin (9) (Siddiqui et al., 2007), and stigmasterol  (Fig. 1).  
The structures of the known compounds were identified by comparison of their physical and 
spectroscopic data with those reported in literature. While, the structures of the new 
compounds were determined on the basis of their spectroscopic data (IR, UV, CD, 1D and 2D 
NMR, MS) and, in the case of 6, also by a single-crystal X-ray crystallographic analysis. 
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Compound 1 was obtained as yellow needles, and its molecular formula, C13H12O4, 
was determined from HRESITOFMS (observed m/z 233.0814 [M + H]+), indicating eight 
degrees of unsaturation.  The UV spectrum showed absorption maxima at 223, 253, 281, and 
350 nm which indicated a highly conjugated naphthalene system.  The IR spectrum showed 
bands for the presence of a hydroxyl (3332 cm-1), an aromatic carbonyl (1616 cm-1), and an 
aromatic (1508 cm-1) system.  The 1H NMR spectrum of 1 (Table 1) showed two doublet 
signals at  7.77 and 7.02 for two aromatic protons, both having a coupling constant of 9.2 
Hz, and a singlet aromatic signal at  7.17. These signals indicated a pentasubstituted 
naphthalene.  A signal at  11.30 (s, 1H) which correlated to a carbonyl carbon ( 199.3) in 
the HSQC spectrum indicated an aldehyde substituent. The other substituents identified 
included a methyl group ( 2.45, s, 3H), a methoxy group ( 3.91, s, 3H), and two hydroxy 
groups (1H, singlets at  6.75 and 14.21).  The HBMC spectrum showed correlations of the 
most downfield hydroxyl proton at  14.21 (2-OH) to C-1 ( 113.1), C-2 ( 166.0), and C-3 
( 119.0); the aldehydic proton (H-9) to C-1, C-2, and C-3; 8-OH ( 6.75) to C-7, C-8 and C-
8a; the methoxy protons to C-7 ( 145.2); and the methyl protons to C-5, C-6 and C-7. The 
last correlation indicated the location of the methyl group at C-6 on the naphthalene ring (Fig. 
2).  The NOESY spectrum of 1 showed correlations between H-3 and H-4, H-5 and H-10, 
and 7-OMe and H-10.  We found that our proposed structure of 1 has been reported as 
hibicuslide C (colorless oil) from Hibiscus taiwanensis (Wu et al., 2005).  However, its 1H 
NMR spectroscopic data did not correlate well with those of 1 but were identical to those of 7 
that we also isolated from this plant. Thus, the structure of hibicuslide C should be revised to 
that of 7. On the basis of the above data, compound 1 was determined to be a new 
trinorcadalene; 2,8-dihydroxy-7-methoxy-6-methyl-1-naphthalenecarbaldehyde and it was 
named as parvifloral A.   
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Compound 2 was obtained as pale yellow needles, and its molecular formula, C14H12O5, 
was determined from HRESITOFMS (observed m/z 283.0603 [M + Na]+), indicating nine 
degrees of unsaturation.  The UV spectrum showed absorption maxima at 224, 238, 259, and 
346 nm indicated a conjugated naphthalene system.  The IR spectrum showed the presence of 
a hydroxyl (3204 cm-1), a lactone (1722 cm-1), and an aromatic (1634 cm-1) system.  The 1H 
and 13C NMR spectra of 2 (Table 1) were similar to those of 1, except for the absence of 
signals for an aldehydic proton at H 11.30 and the downfield hydroxyl proton. The chemical 
shifts of the carbons at C-8 ( 131.3) and C-9 ( 166.3) were in good agreement with those of 
the naphthalenecarbolactone, syriacusin C (8) (Yoo et al., 1998), except for those at C-4 and 
C-2 which were substituted by a hydroxy and a methoxy group, respectively.  The complete 
interpretation of the NMR spectroscopic data of 2 was established as a result of extensive 
DEPT, COSY, HSQC, HMBC, and NOESY experiments (Table 1).  Thus, compound 2 was 
determined to be a new trinorcadalene lactone, and it was named as parvifloral B. 
Compound 3 was obtained as a yellow solid, and its molecular formula, C26H22O8, 
was determined from HRESITOFMS (observed m/z 463.1394 [M + H]+), indicating sixteen 
degrees of unsaturation.  The UV spectrum showed absorption maxima at 227, 255, 282, 353, 
and 391 nm.  The IR spectrum showed bands for the presence of a hydroxyl group (3351 cm-
1) and an aromatic aldehyde (1624 cm-1).  The 13C NMR and DEPT spectra of 3 contained 
only 13 signals which were attributable to a carbonyl group (δ 199.6), eight sp2 quaternary (δ 
165.8, 145.2, 143.9, 129.6, 127.4, 125.6, 120.8, and 113.4) and two sp2 methine (δ 136.1 and 
119.5) carbons, one methyl (δ 13.4), and one methoxy (δ 61.3) group.  Since the 1H and 13C 
NMR spectra (Table 2) showed only half the number of resonances expected for a compound 
having 22 protons and 26 carbons, the structure must be that of a symmetrical dimer.  The 1H 
and 13C NMR spectra of the two monomeric units were similar to those of 1, except for the 
absence of an aromatic proton signal at C-5 which indicated that the two naphthyl units were 
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connected via C-5 and C-5´.  Furthermore, the assignment of the absolute configuration of the 
binaphthyl dimer was concluded to be R from an analysis of its CD spectrum.  The CD 
spectrum of 3 showed a positive Cotton effect at 223 nm (  +70.3) and a negative one at 
237 nm ( -48.6), similar patterns have been reported for the CD spectra of other R-2,2-
homodisubstituted-1,1-binaphthyls  (Di Bari et al., 1999).  Therefore, compound 3 was 
determined to be a new dimer of 1, and it was named as parvifloral C. 
Compound 4 was obtained as light brown needles, and its molecular formula, 
C26H18O8, was determined from HRESITOFMS (observed m/z 481.0899 [M + Na]
+), 
indicating eighteen degrees of unsaturation.  The UV spectrum showed absorption maxima at 
225, 259, and 361 nm.  The IR spectrum showed the presence of hydroxyl (3383 cm-1), 
lactone (1737 cm-1) and aromatic (1626 cm-1) groups.  Since the 1H and 13C NMR spectra 
(Table 2) showed only half the number of resonances expected for a compound having 18 
protons and 26 carbons, the structure of 4 must also be that of a symmetrical dimer.  The 1H 
NMR resonance signals of 4 were similar to those of 8, except for the absence of the aromatic 
signal for H-5, suggesting that the two naphthyl units in 4 were also connected via C-5 and C-
5´.  The absolute configuration of this dimer was deduced to be S from analysis of its CD 
spectrum, which revealed a positive Cotton effect at 230 nm (  +7.6) and a negative one at 
225 nm (  -15.0) (Di Bari et al., 1999).  Therefore, compound 6 was determined to be a 
new dimer of 8, and it was named as parvifloral D.   
Compound 5 was obtained as a yellow solid, and its molecular formula, C26H20O8, 
was determined from HRESITOFMS (observed m/z 461.1236 [M+H]+), indicating seventeen 
degrees of unsaturation.  The UV spectrum showed absorption maxima at 227, 257, 282, and 
361 nm for a naphthalene conjugated system.  The IR spectrum showed the presence of 
hydroxyl (3389 cm-1), lactone (1753 cm-1) and aldehyde (1627 cm-1) groups.  An analysis of 
the 1H and 13C NMR spectroscopic data of 5 (Table 2), including those obtained using 2D 
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NMR techniques (COSY, HSQC, HMBC, and NOESY), indicated that the structure of 5 
contained two different core structures, which were based on compounds 1 and 8.  The 13C 
NMR spectrum of 5 showed resonances for 26 carbons, indicating an unsymmetrical dimer.  
The 1H NMR spectrum of 5 displayed two sets of resonance patterns related to those of 1 and 
8, except for the absence of two aromatic proton signals at C-5 and C-5.  The HMBC 
spectrum of 5 showed a combination of the correlations found in 1 and 8 (Fig. 3). The 
absolute configuration of the binaphthyl system was deduced to be R from its CD spectrum, 
which showed a positive Cotton effect at 226 nm (  +9.3) and a negative one at 247 nm (  
-3.6 )   (Di Bari et al., 1999). Therefore, compound 5 was determined to be a dimer of 1 and 
8, and it was named as parvifloral E.   
Compound 6 was obtained as yellow needles, and its molecular formula, C27H22O9, 
was determined from HRESITOFMS (observed m/z 513.1139 [M+Na]+), indicating 
seventeen degrees of unsaturation.  The UV spectrum showed absorption maxima at 201, 
214, 233, 277, and 399 nm for a naphthalene conjugated system.  The IR spectrum showed 
the presence of hydroxyl (3435 cm-1), ketone (1655 cm-1) and aldehyde (1643 cm-1) groups.  
The 13C NMR and DEPT spectra indicated 27 carbons which were contributable to three 
carbonyl groups (δ 198.5, 190.6, and 181.1), fifteen sp2 quaternary (δ 172.3, 169.2, 163.9, 
150.0, 150.0, 148.2, 136.3, 132.5, 130.4, 128.0, 125.1, 121.7, 119.3, 117.1, and 111.1), one 
sp3 quaternary (94.0) and three sp2 methine (δ 134.8, 124.3, and 89.0) carbons and two 
methyl (δ 11.0 and 10.2), and three methoxy (δ 60.4, 60.0, and 57.2) groups.  The 1H NMR 
spectrum showed three aromatic protons at δ 6.50 (s, H-3), 7.06 (d, J = 9.2 Hz, H-3), and 
6.99 (d, J = 9.2 Hz, H-4).  Two downfield singlet resonances at δ 10.22 and 11.06, which 
correlated to the carbons at δ 190.6 and 198.5, respectively in the HSQC spectrum, revealed 
the presence of the two aldehyde groups in the molecule. While the two downfield singlet 
signals at δ 13.02 and 12.65 were assigned to two chelated OH groups that were H-bonded to 
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the carbonyl oxygens of their nearby aldehyde groups. Three methoxy groups appeared as 
singlet signals at δ 4.06, 3.90, and 3.88.  In addition, the two methyl groups resonated as two 
singlet signals at δ 1.82 and 1.64. The complete interpretation of the NMR data of 6 (Table 2) 
was established as a result of extensive DEPT, COSY, HSQC, HMBC and NOESY 
experiments.  The HMBC technique confirmed the structure of 6 from the correlations of:  (1)  
H-3 to C-1, C-2, C-4 and C-4a; (2) H-4 to C-2, C-3 and C-8a; (3) H-3 to C-1, C-2 and C-4a; 
(4) the aldehydic proton (H-9) to C-1 and C-8a; (5) the aldehydic proton (H-9) to C-1 and C-2 
and C-3; (6) the methyl protons at δ 1.82 to C-5, C-6 and C-7; (7) the methyl protons at δ 
1.64 to C-5, C-6 and C-7; and (8) the methoxy protons at δ 4.06 to C-2, δ 3.90 to C-7, and 
those at δ 3.88 to C-7 (Fig. 4).  The absolute configuration of the binaphthyl system was 
suggested to be R from its CD spectrum, which showed a positive Cotton effect at 220 nm 
(  +4.28) and a negative one at 241 nm ( -0.9) (Di Bari et al., 1999).  Finally, the 
structure of 6 was confirmed by a single-crystal X-ray crystallographic analysis (Fig. 5).  Thus, 
the structure of 6 was deduced as a new unsymmetrical bis-trinorcadalene, and it was named as 
parvifloral F. 
We proposed that compound 6 is derived biosynthetically from an oxidative coupling 
reaction at C-5 between compound 1 and the hypothetical compound 10 to provide a bis-
trinorcadalene in the first step.  Subsequent oxidation of the hydroxy group at C-8 followed by 
a C-O coupling between C-5 and OH-C4´ could then give the dihydrofuran ring of 6 (Fig. 6).  
Although 10 has not been isolated, it is also proposed as a precursor of compound 2 by 
oxidation of the C-9 aldehyde to a carboxylic acid and then lactonization with the hydroxy 
group at C-8 (Fig. 6).   
The biological activities of the isolated compounds are shown in Table 3.  
Compounds 1−9 showed cytotoxicity against the cancer cell lines, KB, MCF7 and NCI-H187 
with IC50 values in the range of 2.20−90.09 M.  Among these, 6 was the most active 
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compound against the KB cell line with an IC50 value of 2.20 M.  Compounds 2 and 6 
exhibited antimalarial activity against Plasmodium falciparum with IC50 values of 11.45 and 
6.85 M, respectively.  Compounds 2, 5, 7 and 8 showed weak antimycobacterial activity 
against Mycobacterium tuberculosis.  In addition, four compounds, 1, 5, 7 and 8, showed 
weak antifungal activity against Candida albicans. 
 
3. Conclusion 
Chromatographic separation of the roots of D. parviflora led to the isolation of ten 
compounds. Their structures were determined using spectroscopic techniques as two new 
trinorcadalenes named as parviflorals A (1) and B (2), four new bis-trinorcadalenes named as 
parviflorals C−F (3−6), along with two known trinorcadalenes, syriacusins A (7) and C (8), a 
known coumarin, scopoletin (9), and a common phytosterol, stigmasterol.  Although the 
structure of 1 has previously been reported, this is the first report of its structure with the 
corrected physical and spectroscopic data.  In addition, the absolute configuration of the bis-
trinorcadalenes (3−6) were deduced from an analysis of their CD spectra.  In addition, the 
structure of 6 was confirmed by a single-crystal X-ray crystallographic analysis.  Finally, the 
isolated compounds, 1−9 were evaluated for their biological activities.   
 
4. Experimental  
4.1. General Experimental Procedures 
Optical rotations and CD spectra were measured on a JASCO DIP-1000 digital 
polarimeter and a JASCO J-815 apparatus, respectively.  UV spectra were recorded using an 
Agilent 8453 UV-visible spectrophotometer.  IR spectra were recorded on a Perkin-Elmer 
Spectrum One spectrophotometer.  NMR spectra were recorded in CDCl3 and CD3OD on a 
Varian Mercury Plus 400 spectrometer, using residual solvent as an internal standard (CHCl3; 
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H 7.26, C 77.0/ MeOH; H 3.30, C 48.7).  HRESITOFMS spectra were recorded on 
Micromass Q-TOF-2 spectrometer.  Column chromatography (CC) was carried out on Merck 
silica gel 60 (230-400 mesh).   TLC and reverse phase TLC were performed with precoated 
Merck silica gel 60 PF254  and silica gel RP-18 F254s aluminum sheets, respectively; the spots 
were visualized under UV light (254 nm and 366 nm) and further by spraying with 
anisaldehyde then heating until charred. 
 
4.2. Plant Materials 
The roots of D. parviflora were collected from Mueng District, Khon Kaen Province 
in November 2008.  A plant specimen (voucher number S. Kanokmedhakul-14) was 
identified by Prof. Pranom Chantaranothai, and was deposited at the herbarium of the 
Department of Biology, Faculty of Science, Khon Kaen University, Thailand.  
 
4.3. Extraction and isolation 
Air-dried roots of D. parviflora (6.1 kg) were ground into a powder and then extracted 
sequentially with hexane and EtOAc (3 x 16 L, three days each) at room temperature.  
Removal of solvents from each extract under reduced pressure gave the crude hexane (133.1 
g) and EtOAc (80.4 g) extracts, respectively. 
The crude hexane extract was separated by flash column chromatography (FCC) over 
silica gel. Elution with a gradient system of EtOAc-hexane and EtOAc-MeOH afforded 5 
fractions designated as HF1−HF5.  Fraction HF2 was filtered and crystallized from hexane to 
give colorless needles of stigmasterol (1.60 g).  Fraction HF3 was purified by FCC over silica 
gel FCC. Eution with EtOAc-hexane (1:4) gave 3 sub-fractions, HF3.1-HF3.3.  The solid from 
sub-fraction HF3.2 was crystallized from hexane to give an additional amount of stigmasterol  
(204.3 mg).  Fraction HF4 was purified by FCC over silica gel, elution with EtOAc-hexane 
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(3:7) gave 3 sub-fractions, HF4.1−HF4.3.  The precipitate of sub-fraction HF4.2 was crystallized 
from CH2Cl2 to give a yellow solid of 3 (804.2 mg).  Sub-fraction HF4.3 was purified by CC 
over silica gel, elution with EtOAc-CH2Cl2 (1:9) gave colorless crystals of 9 (9.1 mg).   
The crude EtOAc extract was separated by FCC over silica gel. Elution with a 
gradient system of EtOAc-hexane and EtOAc-MeOH afforded 5 fractions designated as 
EF1−EF5.  Fraction EF2 was purified by FCC over silica gel, elution with CH2Cl2 gave 3 sub-
fractions, EF2.1−EF2.3.  The precipitate of sub-fraction EF2.2 was purified on reverse phase 
precoated Merck silica gel RP-18 F254S aluminum sheets, elution with MeOH-H2O (1:1) gave 
two yellow compounds 1 (16.4 mg) and 7 (21.7 mg), both of which crystallize as yellow 
needles.  The precipitate of sub-fraction EF2.3 was purified by crystallization from hexane to 
give stigmasterol (3.42 g).  Fraction EF3 was purified by FCC over silica gel, elution with 
EtOAc-hexane (1:4) gave 4 sub-fractions, EF3.1−EF3.4.  Purification of sub-fraction EF3.2 by 
FCC over silica gel and elution with EtOAc-hexane (1:4), gave yellow needles of 6 (15.2 mg) 
and an additional amount of 3 (3.99 g).  Sub-fraction EF3.3 was purified by FCC over silica 
gel, elution with EtOAc-hexane (1:4) gave a yellow solid of 8 (12.3 mg).  Sub-fraction EF3.4 
was purified by FCC over silica gel, elution with EtOAc-CH2Cl2 (1:4) gave pale yellow 
needles of 2 (10.5 mg) and a yellow solid of 5 (72.6 mg).  Fraction EF4 was purified by FCC 
over silica gel, elution with EtOAc-CH2Cl2 (1:9) gave 3 sub-fractions, EF4.1-EF4.3.  Sub-
fraction EF4.2 was crystallized from CH2Cl2-hexane to give an additional amount of 3 (30.1 
mg).  Sub-fraction EF4.3 was crystallized from MeOH-CH2Cl2 to give an additional amount of 
9 (22.4 mg).  Fraction EF5 was purified by FCC over silica gel FCC, elution with MeOH-





4.3.1. Parvifloral A (1) 
Yellow needles; mp 158-160 oC; UV (MeOH) max (log ) 223 (5.08), 253 (4.61), 281 
(4.51), 350 (4.20);  IR (KBr) νmax 3332, 3064, 2942, 2851, 1616, 1508, 1461, 1419, 1355, 
1286, 1151, 1098, 1002, 829 cm-1; 1H and 13C NMR data, see Table 1; HRESITOFMS m/z 
233.0814 [M + H]+ (calcd for C13H12O4 + H
+, 233.0814).  
 
4.3.2. Parvifloral B (2) 
Pale yellow needles; mp 248-250 oC;  UV (MeOH) max (log ) 224 (4.83), 238 
(4.77), 259 (5.03), 346 (4.60);  IR (KBr) νmax 3204, 3008, 1952, 2854, 1722, 1634, 1531, 
1473, 1419, 1383, 1296, 1219, 1052, 958 cm-1; 1H and 13C NMR data, see Table 1; 
HRESITOFMS m/z 283.0603 [M + Na]+ (calcd for C14H12O5 + Na, 283.0582).  
 
4.3.3. Parvifloral C (3) 
Yellow solid; mp 181-183 oC;  []22D +54.8 (c 0.20, EtOH);  UV (MeOH) max (log ) 
227 (4.78), 255 (4.39), 282 (4.25), 353 (3.93), 391 (3.96); CD (EtOH) nm 223 (  +70.3), 
237 (  -48.6); IR (KBr) νmax 3351, 2943, 2856, 1624, 1506, 1464, 1392, 1344, 1282, 1218, 
1173, 1104, 999, 833 cm-1; 1H and 13C NMR data, see Table 2; HRESITOFMS m/z 463.1394 
[M + H]+ (calcd for C26H22O8 + H
+, 463.1393).  
4.3.4. Parvifloral D (4) 
Light brown needles; decomposed at 295 oC;  []22D -18.3 (c 0.20, EtOH);  UV 
(MeOH) max (log ) 225 (5.30), 259 (5.18), 361 (4.86);  CD (EtOH) 225 (  -15.0), 230 (  
+7.6) nm; IR (KBr) νmax 3383, 1992, 2952, 2856, 1737, 1626, 1486, 1386, 1272, 1245, 1149, 
1123, 1036, 957 cm-1; 1H and 13C NMR data, see Table 2;  HRESITOFMS m/z 481.0899 [M 
+ Na]+ (calcd for C26H18O8 + Na, 481.0899).  
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4.3.5. Parvifloral E (5) 
Yellow solid; decomposed at 280 oC; []22D -57.9 (c 0.20, EtOH);  UV (MeOH) max 
(log ) 227 (5.07), 257 (4.84), 282 (4.37), 361 (4.48); CD (EtOH) nm 226 (  +9.3 ), 247 
(  -3.6);  IR (KBr) νmax 3389, 2992, 2948, 2857, 1753, 1627, 1476, 1393, 1270, 1165, 1144, 
1104, 1036, 998, 961, 832 cm-1; 1H and 13C NMR data, see Table 2; HRESITOFMS m/z 
461.1236 [M + H]+ (calcd for C26H20O8 + H
+, 461.1236).  
 
4.3.6. Parvifloral F (6) 
Yellow needles; mp 240-242 oC; []25D -2.43 (c 0.014, MeOH);  UV (MeOH) max 
(log ) 201 (3.64), 214 (3.65), 233 (3.60), 277 (3.37), 399 (2.97); CD (EtOH) nm 220 (  
+4.9), 241 (  +0.9);  IR (KBr) νmax 3435, 2917, 2850, 1655, 1643, 1613, 1571, 1490, 1439, 
1376, 1324, 1202, 1166, 1104, 1058, 898 cm-1; 1H and 13C NMR data, see Table 2; 
HRESITOFMS m/z 513.1139 [M + Na]+ (calcd for C27H22O9 + Na, 513.1162).  
4.3.7. Syriacusin A (7) 
Yellow needles; mp 180-182 oC; UV (MeOH) max (log ) 230 (4.75), 274 (3.75), 365 
(4.02);  IR (KBr) νmax 3238, 2949, 2921, 2851, 1622, 1509, 1479, 1447, 1293, 1234, 1164, 
1060, 924, 814 cm-1; HRESITOFMS m/z 233.0814 [M + H]+ (calcd for C13H12O4 + H
+, 
233.0814).  
4.3.8. Syriacusin C (8) 
Yellow solid; mp 229-231 oC;  UV (MeOH) max (log )  224 (4.68), 253 (4.61), 377 
(4.09); IR (KBr) νmax 3307, 3066, 2956, 2850, 1734, 1642, 1506, 1488, 1342, 1291, 1258, 





4.4. X-ray crystallographic analysis of 6 
 Orange prism-like crystals of 6 were obtained from a mixture of CH2Cl2/MeOH by 
slow evaporation.  X-ray diffraction data were measured on a Bruker-Nonius kappaCCD 
diffractomer with graphite monochromated MoK radiation ( = 0.71073 Å) at 298(2) K.  
The structure was solved by direct methods by SIR97 (Altomare et al, 1999), and refined with 
full-matrix least-squares calculations on F2 using SHELXL-97 (Sheldrick, 2008).  All non-
hydrogen atoms were refined anisotropically and the hydrogen atom positions were 
geometrically idealized and allowed to ride on their parent atoms.  Crystallographic data of 
parvifloral F (6) has been deposited at the Cambridge Crystallographic Data Centre under the 
reference number CCDC 933196. 
 
3.4.1. X-ray data of 6. C27H22O9, M  = 490.46, Monoclinic, dimensions: 0.15  0.20  0.30 
mm, D = 1.423 g/cm3, space group P21/c, Z = 4, a = 7.4460 (2), b = 22.8870 (7), c = 
14.0200(5) Å,  = 106.565 (1)° V = 2290.1 (1) Å3, reflections collected/unique: 7263/2820, 
number of observation [I > 2 (I)] 1982, final R indices [I > 2(I)]: R1 = 0.0791, wR2 = 
0.2090. 
 
4.5. Bioactivity Assays 
4.5.1. Antimalarial Assay 
Antimalarial activity was evaluated against the parasite Plasmodium falciparum (K1, 
multidrugresistant strain), using the method of Trager and Jensen (1967).  Quantitative 
assessment of malarial activity in vitro was determined by means of the microculture 
radioisotope technique based upon the method described by Desjardins et al. (1979).  The 
inhibitory concentration (IC50) represents the concentration that causes 50% reduction in 
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parasite growth as indicated by the in vitro uptake of [3H]-hypoxanthine by P. falciparum.  
The positive control compound was dihydroartemisinin (Table 3). 
 
4.5.2. Antifungal Assay 
An antifungal assay was performed against a clinical isolate of Candida albicans 
using a method modified from the soluble formazan assay described by Scudiero et al. 
(1988). The number of living cells was determined by measuring the absorbance of XTT 
formazan at 450 nm. The reference substance was amphotericin B (Table 3). 
 
4.5.3. Antimycobacterial assay 
Antimycobacterial activity was assessed against M. tuberculosis H37Ra using the 
Microplate Alamar Blue Assay (MABA) (Collins, et al., 1976).  The reference substance was 
streptomycin (Table 3). 
 
4.5.4. Cytotoxicity Assay 
Cytotoxicity assays against the human epidermoid carcinoma (KB), human breast 
cancer (MCF7), and human small cell lung cancer (NCI-H187) cell lines were performed 
employing the colorimetric method as described by Skehan et al. (1990). The reference 
substances were ellipticine and doxorubicin (Table 3). 
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δ H δ C  δ H δ C 
1  113.1   93.7 
2  166.0   161.2 
3 7.02, d (9.2)c 119.0  6.43, s 97.3 
4 7.77, d (9.2) 138.3   163.0 
4a  126.2   110.6 
5 7.17, s 122.8  7.43, s 117.9 
6  127.4   128.4 
7  145.2   140.4 
8  144.1   131.3 
8a  120.1   134.0 
9 11.30, s 199.3   166.3 
10 2.45, s 16.1  2.28, s 17.6 
2-OMe    4.02, s 56.6 
7-OMe 3.91, s 61.0  4.23, s 59.5 
8-OMe      
2-OH 14.21, s     
7-OH      









cValues in parentheses are coupling constants in Hz. 
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δ H δ C  δ H δ C  δ H δ C  δ H δ C 
1  113.4   100.5   113.4   117.1 
2  165.8   158.5   165.8   163.9 
3 6.83, d (9.2) c 119.5  6.86, d (8.8) 118.6  6.82, d (9.2) 119.4  7.06, d (9.2) 124.3 
4 7.13, d (9.2) 136.1  7.12, d (8.8) 134.2  7.19, d (9.2) 136.2  6.99, d (9.2) 134.8 
4a   125.6   119.2   125.4   132.5 
5  129.6   130.0   128.2   94.0 
6  127.4   128.8   127.2   136.3 
7  145.2   140.0   145.0   150.0 d 
8  143.9   167.3   144.0   181.1 
8a   120.8   131.5   120.6   130.4 
9 11.41, s 199.6   131.6  11.41, s 199.6  11.06, s 198.5 
10 1.94, s 13.4  1.93, s 14.3  1.98, s 13.5  1.64, s 11.0 
1  113.4   100.5   100.7   111.1 
2  165.8   158.5   156.8   172.3 
3 6.83, d (9.2)  119.5  6.86, d (8.8) 118.6  6.92, d (8.8) 118.4  6.50, s 89.0 
4 7.13, d (9.2) 136.1  7.12, d (8.8) 134.2  7.12, d (8.8) 134.1   169.2  
4a  125.6   119.2   119.7   121.7 
5  129.6   130.0   131.2   125.1 
6  127.4   128.8   129.7   128.0 
7  145.2   140.0   140.3   150.0 d 
8  143.9   167.3   131.4   148.2 
8a  120.8   131.5   130.8   119.3 
9 11.41, s 199.6   131.6   167.6  10.22, s 190.6 
10 1.94, s 13.4  1.93, s 14.3  1.94, s 14.3  1.82, s 10.2 
OH-2  14.16      14.15, s   12.65, s  
OH-8  6.94      7.02, s     
7-OMe 3.96 61.3  4.36, s 59.9  3.96, s 61.3  3.88, s 60.0 
OH-2  14.16           
OH-8  6.94         13.02, s  
7-OMe 3.96 61.3  4.36, s 59.9  4.41, s 60.0  3.90, s 60.4 




Table 3. Biological activities of the isolated compounds 
 
compound 
antimalariala antifungalb anti-TBb cytotoxicity (IC50, µM)
b 
(IC50, µM) (IC50, µM) (MIC, µM) KB
c MCF7d NCI-H187e 
1 inactive 64.50 inactive 3.88 16.66 36.64 
2 11.45 inactive 192.13 37.43 nd 14.68 
3 inactive nd nd 36.05 76.03 36.05 
4 inactive inactive inactive inactive nd inactive 
5 inactive 92.93 54.30 5.56 20.50 29.06 
6 6.85 inactive nd 2.20 inactive 31.22 
7 inactive 37.03 107.65 9.73 33.37 4.99 
8 inactive 197.68 54.30 90.09 nd inactive 
9 inactive inactive inactive 66.24 inactive inactive 
dihydroartemisinin 0.004      
amphotericin B  0.06     
streptomycin   0.27-0.54    
ellipticine    0.78  5.64 
doxorubicin    0.29 0.13 0.13 
 
a Inactive at final concentration 10 µg/mL. 
b Inactive at final concentration 50 µg/mL. 
c Human oral epidermoid carcinoma. 
d Human breast cancer cells.  
e Human small cell lung cancer. 
  nd = not determined 
 
